Asset Details
Do you wish to reserve the book?
Hot and Cold HCC: Uncoupling Viral Oncogenesis and Therapy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Hot and Cold HCC: Uncoupling Viral Oncogenesis and Therapy
Do you wish to request the book?
Hot and Cold HCC: Uncoupling Viral Oncogenesis and Therapy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Hot and Cold HCC: Uncoupling Viral Oncogenesis and Therapy
2025
Overview
Hepatocellular carcinoma (HCC) is rising in incidence globally. It is the sixth most common cancer and the third leading cause of cancer-related mortality worldwide. Infection with hepatitis B and/or C virus is a significant risk factor for developing HCC. These viruses exert their carcinogenicity in both direct and indirect ways, including induction of immune exhaustion with prolonged antigen exposure. Therefore, the best therapeutic option for HCC is prevention, i.e., Hepatitis B vaccination and treatment of viral hepatitis. However, when HCC develops because of viral hepatitis or other etiologies, long-lasting effects on the immune system remain even after viral suppression, which affect the response to HCC therapy. Recent studies have suggested a “hot” and “cold” model for HCC, in which the two kinds of HCC tumors have very distinct tumor microenvironments. The microenvironment for hot HCC makes these tumors amenable to immunotherapy with checkpoint inhibitors. Therefore, converting cold HCC tumors to hot tumors may make them susceptible to immunotherapy. In this review, we provide an overview of HCC epidemiology and prevention, an overview of tumor microenvironments of hot and cold HCC, the proposed mechanisms for converting cold tumors to hot tumors, and a concise summary of the evidence for combination checkpoint inhibitor therapy for HCC.
Publisher
MDPI AG
Subject
/ Animals
/ Antigens
/ B cells
/ Carcinoma, Hepatocellular - epidemiology
/ Carcinoma, Hepatocellular - etiology
/ Carcinoma, Hepatocellular - immunology
/ Carcinoma, Hepatocellular - therapy
/ Carcinoma, Hepatocellular - virology
/ Diabetes
/ Genomes
/ Humans
/ Immune checkpoint inhibitors
/ Immune Checkpoint Inhibitors - therapeutic use
/ Liver Neoplasms - epidemiology
/ Liver Neoplasms - immunology
/ Mutation
/ Obesity
/ Tumors
We currently cannot retrieve any items related to this title. Kindly check back at a later time.